Nitin Trivedi to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Nitin Trivedi has written about Diabetes Mellitus, Type 2.
Connection Strength
1.464
-
Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkit NR, Gogtay M, Lal A, Abraham GM, Trivedi N. Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus. Respir Med. 2024 Nov-Dec; 234:107819.
Score: 0.551
-
Lal A, Haque N, Lee J, Katta SR, Maranda L, George S, Trivedi N. Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study. Acta Biomed. 2021 02 25; 92(1):e2021036.
Score: 0.430
-
Thapa SS, Lal A, Omer A, Trivedi N. Elevated ?-hydroxybutyric acid with no ketoacidosis in type 2 diabetic patients using sodium-glucose cotransporter-2 inhibitors. J Formos Med Assoc. 2019 10; 118(10):1473-1474.
Score: 0.380
-
Upadhyay J, Trivedi N, Lal A. Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation. Lung. 2020 06; 198(3):525-533.
Score: 0.102